<DOC>
	<DOCNO>NCT01783691</DOCNO>
	<brief_summary>The purpose study determine safety , pharmacokinetics , pharmacodynamics NKTT120 adult patient stable sickle cell disease .</brief_summary>
	<brief_title>Safety , Pharmacokinetic , Pharmacodynamic Study NKTT120 Adult Patients With Stable Sickle Cell Disease ( SCD )</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Age 18 50 year Subject confirm diagnosis HbSS HbSÎ²0thal Subject stable SCD define acute VOC , ACS , major SCD associate event month prior enrollment Subject SCDrelated VOC ACS require hospitalization treatment acute care outpatient set month prior enrollment Subject require program prescheduled regularly administer packed red blood cell ( pRBC ) transfusion Subject receive pRBC transfusion month prior enrollment Subject evidence latent active tuberculosis Subject major concurrent illness medical condition Subject pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Sickle cell disease</keyword>
</DOC>